Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.8231
-0.0069 (-0.83%)
At close: Jan 14, 2026, 4:00 PM EST
0.8442
+0.0211 (2.56%)
After-hours: Jan 14, 2026, 6:04 PM EST
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $4.51 million as of January 14, 2026. Its market cap has decreased by -4.00% in one year.
Market Cap
4.51M
Enterprise Value
-14.61M
1-Year Change
-4.00%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $4.51M, a decrease of -96.90%. That is a compound annual growth rate of -25.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 4.50M | 9.76% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |